Inflammatix (Series C)
Funding Details
Awarder
Inbox
Date Award
January 10, 2020
Vertical
Molecular Diagnostics
Funding Amount
$32,000,000
Company Info
Market
Healthcare
Location
Burlingame, California, USA
Coinvestors
Grey Sky Venture Partners, Northpond Ventures, Think.Health Ventures
Company Description

Inflammatix develops rapid immune system diagnostics to improve patient care and public health.